Henan Lingrui Pharmaceutical Co Ltd (600285) — Financial Flexibility Index
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥145.72 Million (operating CF CN¥140.12 Million minus capex CN¥5.61 Million) represents 0% of total liabilities (CN¥2.47 Billion). Also explore 600285 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Henan Lingrui Pharmaceutical Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Henan Lingrui Pharmaceutical Co Ltd across 27 annual periods. Check 600285 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Henan Lingrui Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Henan Lingrui Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.28x | CN¥610.71 Million | CN¥553.88 Million | CN¥2.20 Billion | ▼ -45.7% |
| 2024 | 0.51x | CN¥990.97 Million | CN¥875.86 Million | CN¥1.94 Billion | ▲ +21.0% |
| 2023 | 0.42x | CN¥834.63 Million | CN¥813.43 Million | CN¥1.97 Billion | ▼ -12.4% |
| 2022 | 0.48x | CN¥861.90 Million | CN¥834.91 Million | CN¥1.79 Billion | ▼ -21.2% |
| 2021 | 0.61x | CN¥922.59 Million | CN¥845.69 Million | CN¥1.51 Billion | ▲ +33.1% |
| 2020 | 0.46x | CN¥522.35 Million | CN¥450.53 Million | CN¥1.14 Billion | ▼ -1.1% |
| 2019 | 0.46x | CN¥509.19 Million | CN¥450.15 Million | CN¥1.10 Billion | ▼ -3.3% |
| 2018 | 0.48x | CN¥488.39 Million | CN¥436.25 Million | CN¥1.02 Billion | ▲ +46.0% |
| 2017 | 0.33x | CN¥363.53 Million | CN¥105.97 Million | CN¥1.10 Billion | ▲ +1.8% |
| 2016 | 0.32x | CN¥281.31 Million | CN¥63.26 Million | CN¥869.35 Million | ▲ +32.2% |
| 2015 | 0.24x | CN¥241.05 Million | CN¥156.82 Million | CN¥984.58 Million | ▼ -1.2% |
| 2014 | 0.25x | CN¥226.42 Million | CN¥124.32 Million | CN¥913.70 Million | ▼ -44.1% |
| 2013 | 0.44x | CN¥294.15 Million | CN¥127.27 Million | CN¥663.24 Million | ▲ +128.5% |
| 2012 | 0.19x | CN¥115.96 Million | CN¥15.43 Million | CN¥597.36 Million | ▼ -2.6% |
| 2011 | 0.20x | CN¥104.39 Million | CN¥40.49 Million | CN¥524.02 Million | ▲ +169.7% |
| 2010 | 0.07x | CN¥36.14 Million | CN¥-3.95 Million | CN¥489.25 Million | ▼ -84.3% |
| 2009 | 0.47x | CN¥177.69 Million | CN¥132.61 Million | CN¥378.52 Million | ▲ +154.0% |
| 2008 | 0.18x | CN¥77.35 Million | CN¥43.72 Million | CN¥418.55 Million | ▲ +10.4% |
| 2007 | 0.17x | CN¥60.83 Million | CN¥15.99 Million | CN¥363.31 Million | ▲ +51.5% |
| 2006 | 0.11x | CN¥43.32 Million | CN¥26.76 Million | CN¥392.03 Million | ▼ -17.5% |
| 2005 | 0.13x | CN¥52.58 Million | CN¥33.43 Million | CN¥392.44 Million | ▼ -36.8% |
| 2004 | 0.21x | CN¥76.16 Million | CN¥35.51 Million | CN¥359.36 Million | ▼ -5.0% |
| 2003 | 0.22x | CN¥64.60 Million | CN¥23.79 Million | CN¥289.65 Million | ▼ -49.2% |
| 2002 | 0.44x | CN¥123.47 Million | CN¥69.41 Million | CN¥281.00 Million | ▲ +71.2% |
| 2001 | 0.26x | CN¥40.70 Million | CN¥3.41 Million | CN¥158.59 Million | ▼ -34.1% |
| 2000 | 0.39x | CN¥41.42 Million | CN¥3.66 Million | CN¥106.33 Million | ▲ +321.0% |
| 1999 | 0.09x | CN¥10.45 Million | CN¥4.81 Million | CN¥112.94 Million | — |